Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02412540 · ClinicalTrials.gov registry record · NA

Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH

A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
62
Enrollment target

NCT02412540: Completed NA study, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT02412540 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02412540, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

The goal of this study is to determine effective treatment and identify diagnostic biomarkers for Nonalcoholic steatohepatitis (NASH). Individuals that take part in the study will be participating in either a weight loss surgery (WLS) group or a comprehensive lifestyle intervention (CLI) group. People in the WLS group will receive vertical sleeve gastrectomy (VSG). The CLI group will receive dietary, activity and behavioral interventions provided by trained study staff.

Primary Outcome

Proportion of subjects achieving greater than 2 point reduction in NASH activity score (NAS) across at least two separate histological components of the NAS score (steatosis, inflammation and ballooning) and no worsening of fibrosis stage.

Interventions

  • BEHAVIORAL Comprehensive Lifestyle Intervention

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2015-04-23
Est. Completion 2021-03-02
Phase NA

What the finished NCT02412540 record still lists

NCT02412540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Comprehensive Lifestyle Intervention is the first listed.

NCT02412540 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02412540 about?

NCT02412540 is a clinical study titled "Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASH". The goal of this study is to determine effective treatment and identify diagnostic biomarkers for Nonalcoholic steatohepatitis (NASH). Individuals that take part in the study will be participating in either a weight loss surgery (WLS) group or a comprehensive lifestyle intervention (CLI) group. Peop...

What is the current status of trial NCT02412540?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-04-23. Estimated completion is 2021-03-02.

What interventions are being tested in trial NCT02412540?

The interventions under investigation include: Comprehensive Lifestyle Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02412540?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02412540's enrollment target sits among peer trials

62 1157th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02412540, the US trial registry maintained by the National Library of Medicine. NCT02412540 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.